Specifically, even though EMA and PR are considered some of the most reliable and sensitive immunohistochemical markers for meningiomas, they could be negative in a few of them [7] and, above all, they are expressed by a significant percentage of SFT/HPCs [2, 3]. The gene discussed is PGR; the disease is meningioma.